EUVIMEDEUVIMED entdecken
Crossref

Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells

Soyoung A Oh, Akiko Seki, Sascha Rutz

Current Protocols in Immunology · 2019-02 · 124 (1)

DOI: 10.1002/cpim.69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols in Immunology, online erschienen am 18.10.2018. Verfasst von Soyoung A Oh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology, Genentech, South San Francisco, California. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR/Cas9 has enabled the rapid and efficient generation of gene knockouts across various cell types of several species. T cells are central players in adaptive immune responses. Gene editing in primary T cells not only represents a valuable research tool, but is also critical for next generation immunotherapies, such as CAR T cells. Broad application of CRIPSR/Cas9 for gene editing in primary T cells has been hampered by limitations in transfection efficiency and the requirement for TCR stimulation. In this article, we provide a detailed protocol for Cas9/gRNA ribonucleoprotein (RNP) transfection of primary mouse and human T cells without the need for TCR stimulation that achieves near complete loss of target gene expression at the population level. This approach enables rapid target discovery and validation in both mouse and human primary T cells. © 2018 by John Wiley & Sons, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCRISPR-Cas SystemsGene EditingHumansMiceMice, KnockoutRibonucleoproteinsTransfection

Stichwörter der Autor:innen

CRISPRCas9RNPgRNAgene knockoutnucleofectionprimary human T cellsprimary mouse T cells

Substanzen

Ribonucleoproteins

Autor:innen und Institutionen

  • Department of Cancer Immunology, Genentech, South San Francisco, California.

Zitieren

APA

Oh, S. A., Seki, A., & Rutz, S. (2019). Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells. Current Protocols in Immunology, 124(1). https://doi.org/10.1002/cpim.69

Vancouver

Oh SA, Seki A, Rutz S. Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells. Current Protocols in Immunology. 2019;124(1). doi:10.1002/cpim.69

BibTeX
@article{Oh2019,
  author = {Oh, Soyoung A and Seki, Akiko and Rutz, Sascha},
  title = {Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells},
  journal = {Current Protocols in Immunology},
  year = {2019},
  volume = {124},
  number = {1},
  doi = {10.1002/cpim.69}
}
Kostenlos starten →